second quarter sales of $404 million, down 28% from the prior year reflecting the impact of covid-19.
qtrly adjusted diluted earnings per share from continuing operations of $0.31, which excludes impact of cares act support, other items.
q2 adjusted earnings per share $0.31 from continuing operations excluding items.
q2 sales $404 million versus refinitiv ibes estimate of $409.4 million.
